RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1200%2Fjco.22.00327

https://w3id.org/ripe/ripe-kg/work/10.1200%2Fjco.22.00327
SubjectPredicateObject
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial prism:doi 10.1200/jco.22.00327
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial dcterms:title Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial rdf:type node1
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial rdf:type rdfs:Resource
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial rdf:type owl:Thing
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial rdf:type prov:Entity
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial rdf:type ripe:WorkWork
ripekg:work/10.1200%2Fjco.22.00327Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial owl:sameAs https://semopenalex.org/work/W4282962945